Elite PharmaceuticalsELTP 
$0.349.68%24h
9.68%24h
Global rank13755
Market cap$344.39M
Change 7d21.43%
YTD Performance142.86%
SP500 benchmarkOutperform
P/E96.70
P/S10.08
Revenue$34.16M
Earnings$3.56M
Dividend yield-
Main Sector
Healthcare
Elite Pharmaceuticals ELTP Total Debt
ELTP Total Debt in 2022: $3.56M
According to Elite Pharmaceuticals latest financial reports the total debt is $3.56M, an increase of 60.08% to 2022. At the end of 2022 company had $2.22M total debt. This figure represents the debts and financial obligations that Elite Pharmaceuticals combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Elite Pharmaceuticals ELTP Total Debt History from 2023 to 2022
-
Value:-
ELTP Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $3.56M | 60.08% |
| 2022 | $2.22M | 25.02% |
| 2021 | $1.78M | -9.55% |
| 2020 | $1.97M | -40.86% |
| 2019 | $3.33M | - |
View the Top Total Debt Stocks 
